Sarepta Therapeutics, Inc. — Director's Dealing 2021

Mar 11, 2021

SEC Form 4/A — Form 4/A

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2021-02-28

Reporting Person: Rodino-Klapac Louise (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-28	Common Stock	F	565	$86.97	Disposed	6604	Direct
2021-03-03	Common Stock	A	15000	$0.00	Acquired	21780	Direct

Footnotes

F1: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020.

F2: On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021.

F3: The amount of securities directly owned by the reporting person includes 176 shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan on February 28, 2021.